If you are deciding what to do with Sankyo stock right now, you are definitely not alone. The conversation around Sankyo has heated up in recent months and for good reason, especially if you have been ...

TOKYO, June 10 (Reuters) - Shares in Daiichi Sankyo <4568.T> have nearly halved from a year-ago peak when Japan's No.3 drug maker agreed to buy India's generic drug maker Ranbaxy Laboratories . The ...

TOKYO, Jan 5 (Reuters) - Japan's third-largest drugmaker, Daiichi Sankyo Co <4568.T>, said on Monday it would book an appraisal loss of 359.5 billion yen ($3.9 billion) on a parent-company basis on ...